186 related articles for article (PubMed ID: 35558978)
1. A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome.
Yi Z; Tan Y; Liu Y; Jiang L; Luo L; Wang L; Lei W; Tan J; Yan R
Transl Pediatr; 2022 Apr; 11(4):526-536. PubMed ID: 35558978
[TBL] [Abstract][Full Text] [Related]
2. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
Tang W; Chen S; Shi D; Ai T; Zhang L; Huang Y; Fan Y; Du Y
Pediatr Pulmonol; 2022 Feb; 57(2):455-469. PubMed ID: 34783192
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia.
Gharehbaghi MM; Ganji S; Mahallei M
Oman Med J; 2021 Jul; 36(4):e289. PubMed ID: 34447583
[TBL] [Abstract][Full Text] [Related]
6. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
7. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
8. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
9. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
[TBL] [Abstract][Full Text] [Related]
10. Synthetic surfactant for respiratory distress syndrome in preterm infants.
Soll RF
Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
Ke H; Li ZK; Yu XP; Guo JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):400-4. PubMed ID: 27165587
[TBL] [Abstract][Full Text] [Related]
12. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
13. Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review.
Nobile S; Di Sipio Morgia C; Hall M
Am J Perinatol; 2024 May; 41(S 01):e1858-e1865. PubMed ID: 37279790
[TBL] [Abstract][Full Text] [Related]
14. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
16. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
Xu H; Xu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
[TBL] [Abstract][Full Text] [Related]
18. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
Heo M; Jeon GW
Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
[TBL] [Abstract][Full Text] [Related]
19. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Bahadue FL; Soll R
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD001456. PubMed ID: 23152207
[TBL] [Abstract][Full Text] [Related]
20. [Safety evaluation on different ventilation strategies set for neonatal respiratory distress syndrome: a network Meta-analysis].
Wu J; Wen ZH; Liu DD; Wu CF; Zhang Y; Zhang L; Xu YL; Yang G; Jing CX
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):249-260. PubMed ID: 32164138
[No Abstract] [Full Text] [Related]
[Next] [New Search]
